The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma
Crossref DOI link: https://doi.org/10.1007/s11060-017-2599-1
Published Online: 2017-08-23
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Youland, Ryan S.
Kreofsky, Cole R.
Schomas, David A.
Brown, Paul D.
Buckner, Jan C.
Laack, Nadia N.
License valid from 2017-08-23